A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial.

Background/aims: Participant recruitment to diabetes prevention randomised controlled trials is challenging and expensive. The T4DM study, a multicentre, Australia-based, Phase IIIb randomised controlled trial of testosterone to prevent Type 2 diabetes in men aged 50–74 years, faced the challenge of...

Descripción completa

Detalles Bibliográficos
Publicado en:Clinical Trials Vol. 16; no. 6; pp. 589 - 599
Autores principales: Bracken, Karen, Keech, Anthony, Hague, Wendy, Allan, Carolyn, Conway, Ann, Daniel, Mark, Gebski, Val, Grossmann, Mathis, Handelsman, David J, Inder, Warrick J, Jenkins, Alicia, McLachlan, Robert, Robledo, Kristy P, Stuckey, Bronwyn, Yeap, Bu B, Wittert, Gary
Formato: pictorial research tables/charts Journal Article
Publicado: Sage Publications, Ltd. Dec2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=140293281&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 140293281
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17407745
        AB6
      jtl: Clinical Trials
      issn: 17407745
      maglogo: N
    pubinfo:
      dt: Dec2019
      vid: 16
      iid: 6
      pid: 33180
      pub: Sage Publications, Ltd.
      place: <Blank>
    artinfo:
      ui:
        140293281
        140293281
        140293281
        10.1177/1740774519872999
        140293281
      ppf: 589
      ppct: 10
      formats:
      tig:
        atl: A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial.
      aug:
        au:
          Bracken, Karen
          Keech, Anthony
          Hague, Wendy
          Allan, Carolyn
          Conway, Ann
          Daniel, Mark
          Gebski, Val
          Grossmann, Mathis
          Handelsman, David J
          Inder, Warrick J
          Jenkins, Alicia
          McLachlan, Robert
          Robledo, Kristy P
          Stuckey, Bronwyn
          Yeap, Bu B
          Wittert, Gary
        affil: NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia
      sug:
        subj:
          Diabetes Mellitus, Type 2 Prevention and Control
          Testosterone Therapeutic Use
          Randomized Controlled Trials
          Research Subject Recruitment Methods
          Health Screening Methods
          Health Screening Economics
          Human
          Male
          Australia
          World Wide Web
          Laboratory Test Panels
          Data Collection Methods
          Eligibility Determination
          Automation
          Email
          Communication
          Database Management Software
          Cost Savings
          Male
      ab: Background/aims: Participant recruitment to diabetes prevention randomised controlled trials is challenging and expensive. The T4DM study, a multicentre, Australia-based, Phase IIIb randomised controlled trial of testosterone to prevent Type 2 diabetes in men aged 50–74 years, faced the challenge of screening a large number of prospective participants at a small number of sites, with few staff, and a limited budget for screening activities. This article evaluates a high-volume, low-cost, semi-automated approach to screen and enrol T4DM study participants. Methods: We developed a sequential multi-step screening process: (1) web-based pre-screening, (2) laboratory screening through a network of third-party pathology centres, and (3) final on-site screening, using online data collection, computer-driven eligibility checking, and automated, email-based communication with prospective participants. Phone- and mail-based data collection and communication options were available to participants at their request. The screening process was administered by the central coordinating centre through a central data management system. Results: Screening activities required staffing of approximately 1.6 full-time equivalents over 4 years. Of 19,022 participants pre-screened, 13,108 attended a third-party pathology collection centre for laboratory screening, 1217 received final, on-site screening, and 1007 were randomised. In total, 95% of the participants opted for online pre-screening over phone-based pre-screening. Screening costs, including both direct and staffing costs, totalled AUD1,420,909 (AUD75 per subject screened and AUD1411 per randomised participant). Conclusion: A multi-step, semi-automated screening process with web-based pre-screening facilitated low-cost, high-volume participant enrolment to this large, multicentre randomised controlled trial. Centralisation and automation of screening activities resulted in substantial savings compared to previous, similar studies. Our screening approach could be adapted to other randomised controlled trial settings to minimise the cost of screening large numbers of participants.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N